Dexcom (DXCM) Change in Receivables (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Receivables data on file, last reported at -$124.6 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at -$124.6 million, down 183.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$71.6 million (down 140.2% YoY), and the FY2025 annual result was $201.9 million, up 476.86% from the prior year.
• Change in Receivables eased to -$124.6 million in Q1 2026 per DXCM's latest filing, from $106.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $187.2 million in Q4 2023 and troughed at -$237.8 million in Q3 2025.
• A 5-year average of $33.7 million and a median of $30.1 million in 2022 frame the typical range for Change in Receivables.
• On a YoY basis, Change in Receivables climbed as much as 2467.24% in 2025 and fell as far as 527.7% in 2025.
• A 5-year view of Change in Receivables shows it stood at $148.3 million in 2022, then grew by 26.23% to $187.2 million in 2023, then sank by 96.05% to $7.4 million in 2024, then soared by 1335.14% to $106.2 million in 2025, then plunged by 217.33% to -$124.6 million in 2026.
• Business Quant data shows DXCM's Change in Receivables at -$124.6 million in Q1 2026, $106.2 million in Q4 2025, and -$237.8 million in Q3 2025.